Complexity of complement activation in sepsis.
The complement system is one of the key players in the defence against infections. Its activation during the innate immune response leads to the generation of several proteins that contribute to the lysis and opsonization of microorganisms, regulate inflammatory reactions and bridge innate immunity with the subsequent adaptive immune response. Complement is also activated in overwhelming bacterial infections that lead to sepsis, and its protective functions play a role in this frequently lethal disorder. However, despite its role in protection, complement can also contribute to the development of severe complications that significantly worsen the prognosis of septic patients. Therefore, an understanding of the mechanisms involved in the activation of complement during sepsis is essential to our efforts to introduce rational therapies targeting complement to the treatment of patients suffering from this condition. This review presents a current view of the mechanisms involved in the activation of complement in sepsis, in the context of the multiple interactions between complement and other biological systems that are involved in the pathogenesis of this disorder.
Markiewski
Maciej M
MM
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
DeAngelis
Robert A
RA
Lambris
John D
JD
D001424:Bacterial Infections / Q000097:blood / Q000276:immunology; D003167:Complement Activation / Q000502:physiology*; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D018448:Models, Immunological; D018805:Sepsis / Q000097:blood / Q000209:etiology / Q000276:immunology*
J Immunol. 2008 Mar 15;180(6):4124-32
18322223
J Leukoc Biol. 2008 Mar;83(3):467-70
17875813
J Thromb Haemost. 2008 Aug;6(8):1413-21
18503629
Crit Care Med. 2007 Sep;35(9):2191-5
17855836
Annu Rev Immunol. 2005;23:337-66
15771574
J Exp Med. 1982 Jul 1;156(1):205-16
6177820
N Engl J Med. 2001 Apr 5;344(14):1058-66
11287977
N Engl J Med. 2003 Apr 17;348(16):1546-54
12700374
J Immunol. 1985 Oct;135(4):2695-700
4031497
Immunol Res. 1997;16(2):127-36
9212359
J Immunol. 2006 Feb 1;176(3):1305-10
16424154
Trends Immunol. 2002 Feb;23(2):61-4
11929126
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11490-4
8524789
J Clin Invest. 1983 May;71(5):1450-6
6304147
J Biol Chem. 2006 Jan 27;281(4):2128-32
16301317
Nature. 1987 Dec 17-23;330(6149):662-4
3317066
Nature. 1990 Dec 6;348(6301):550-2
2147233
Immunol Res. 2006;34(2):157-76
16760575
Clin Chim Acta. 1976 Nov 15;73(1):171-5
826358
Clin Immunol. 2006 Feb-Mar;118(2-3):127-36
16338172
J Immunol. 2008 May 1;180(9):6132-8
18424734
Crit Care Med. 2001 Jul;29(7):1303-10
11445675
Int Immunol. 2003 Feb;15(2):177-86
12578847
Trends Immunol. 2007 Apr;28(4):184-92
17336159
J Thromb Haemost. 2006 Jan;4(1):90-7
16409457
Biochem J. 1988 Jan 15;249(2):495-500
3277626
J Exp Med. 1981 Jun 1;153(6):1391-404
6910482
J Exp Med. 2005 Mar 21;201(6):871-9
15781579
Nature. 2002 Dec 19-26;420(6917):846-52
12490957
Am J Pathol. 1975 Mar;78(3):525-36
1091153
Adv Exp Med Biol. 2006;586:203-16
16893074
Am J Pathol. 2007 Sep;171(3):715-27
17640961
Am J Respir Crit Care Med. 2002 Nov 1;166(9):1197-205
12403688
Intensive Care Med. 2002 Feb;28(2):108-21
11907653
Adv Exp Med Biol. 2008;632:71-9
19025115
J Immunol. 2007 Aug 15;179(4):2600-8
17675523
Blood. 2008 Jan 15;111(2):732-40
17916747
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9023-8
18579773
Annu Rev Immunol. 2005;23:821-52
15771587
Nature. 2002 Dec 19-26;420(6917):885-91
12490963
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16969-74
12477926
Nat Rev Microbiol. 2008 Feb;6(2):132-42
18197169
J Immunol. 2004 Jan 15;172(2):1198-202
14707097
J Immunol. 1983 Jul;131(1):416-22
6602834
Mol Immunol. 2005 May;42(8):927-30
15829284
Chest. 1992 Jun;101(6):1644-55
1303622
Lancet Infect Dis. 2008 Jan;8(1):32-43
18063412
J Exp Med. 1994 Feb 1;179(2):569-78
8294868
J Exp Med. 2001 Sep 17;194(6):781-95
11560994
Crit Care Med. 2005 Feb;33(2):341-8
15699837
Blood. 2002 Oct 15;100(8):2908-16
12351402
Cell. 2006 Apr 7;125(1):47-58
16615889
J Immunol. 1995 Jun 15;154(12):6502-10
7539023
N Engl J Med. 1999 Jan 21;340(3):207-14
9895401
J Thromb Haemost. 2006 Sep;4(9):2035-42
16961611
Nat Immunol. 2004 Oct;5(10):981-6
15454921
J Exp Med. 2004 Dec 6;200(11):1383-93
15583012
Mol Immunol. 2007 Mar;44(7):1631-8
17049606
J Immunol. 1997 Jul 15;159(2):976-82
9218619
Cleve Clin J Med. 2008 Mar;75(3):177-80, 183-6, 190-2
18383927
Nat Biotechnol. 2007 Nov;25(11):1265-75
17989689
J Pathol. 2008 Jan;214(2):211-23
18161754
Medicine (Baltimore). 1984 Sep;63(5):243-73
6433145
J Immunol. 2002 Oct 15;169(8):4430-6
12370377
Am J Med. 2007 Dec;120(12):1012-22
18060918
Science. 1985 Aug 30;229(4716):869-71
3895437
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):215-20
14694198
Nat Med. 2006 Jun;12(6):682-7
16715088